Journal of the American College of Surgeons
Volume 209, Issue 4 , Pages 504-520 , October 2009

Image-Detected Breast Cancer: State-of-the-Art Diagnosis and Treatment

Received 13 July 2009 ,Accepted 20 July 2009.

References 

  1. International Breast Cancer Consensus Conference. Image-detected breast cancer: state of the art diagnosis and treatment. J Am Coll Surg. 2001;193:297–302
  2. Silverstein MJ, Lagios MD, Recht A, et al. Image-detected breast cancer: state of the art diagnosis and treatment. J Am Coll Surg. 2005;201:586–597
  3. Pisano ED, Gatsonis C, Hendrick E, et al. Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med. 2005;353:1773–1783
  4. American College of Radiology. BI-RADS® – Ultrasound, first edition. http://www.acr.org/SecondaryMainMenuCategories/quality_safety/BIRADSAtlas/BIRADSAtlasexcerptedtext/BIRADSUltrasoundFirstEdition.aspx2003;Accessed June 13, 2009
  5. Berg WA, Blume JD, Cormack JB, et al. Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA. 2008;299:2151–2163
  6. Drew P, Turnbull L, Harvey I, et al. MR imaging in breast cancer- results of the COMICE trial (abstract 5). Eur J Surg Oncol. 2008;34:1156
  7. Saslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 2007;57:75–89
  8. American College of Radiology. ACR practice guideline for the performance of contrast-enhanced magnetic resonance imaging (MRI) of the breast. http://www.acr.org/SecondaryMainMenuCategories/quality_safety/guidelines/breast/mri_breast.aspx2008;Accessed July 5, 2009
  9. American College of Radiology. BI-RADS® – MRI, first edition. http://www.acr.org/SecondaryMainMenuCategories/quality_safety/BIRADSAtlas/BIRADSAtlasexcerptedtext/BIRADSMRIFirstEdition.aspx2003;Accessed June 13, 2009
  10. Consensus Conference Committee. Consensus conference on the classification of ductal carcinoma in situ. Cancer. 1997;80:1798–1802
  11. Lester SC, Bose S, Chen YY, et al. Protocol for the examination of specimens from patients with ductal carcinoma in situ of the breast. Arch Pathol Lab Med. 2009;133:15–25
  12. Veronesi U, Galimberti V, Mariani L, et al. Sentinel node biopsy in breast cancer: early results in 953 patients with negative sentinel node biopsy and no axillary dissection. Eur J Cancer. 2005;41:231–237
  13. Tjan-Heijnen VC, Pepels MJ, de Boer M, et al. Impact of omission of completion axillary lymph node dissection (cALND) or axillary radiotherapy (ax RT) in breast cancer patients with micrometastases (pN1mi) or isolated tumor cells (pN0[i+]) in the sentinel lymph node (SN): Results from the MIRROR study (abstract CRA506). J Clin Oncol. 2009;27:803s
  14. Viani GA, Stefano EJ, Afonso SL, et al. Breast-conserving surgery with or without radiotherapy in women with ductal carcinoma in situ: a meta-analysis of randomized trials. Radiat Oncol. 2007;2:28
  15. National Comprehensive Cancer Network. Breast cancer - v.1.2009. http://www.nccn.org/professionals/physician_gls/PDF/breast.pdf2009;Accessed July 5, 2009
  16. Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366:2087–2106
  17. Polgár C, Fodor J, Major T, et al. Breast-conserving treatment with partial or whole breast irradiation for low-risk invasive breast carcinoma–5-year results of a randomized trial. Int J Radiat Oncol Biol Phys. 2007;69:694–702
  18. Keisch M, Arthur D, Patel R, et al. American Brachytherapy Society Breast Brachytherapy Task Group. 2007. Available at: www.americanbrachytherapy.org/…/abs_breast_brachytherapy_taskgroup.pdf. Accessed July 4, 2009.
  19. American Society of Breast Surgeons. Consensus statement for accelerated partial breast irradiation. http://www.breastsurgeons.org/statements/index.php/APBI_statement_revised_10/07/08.pdf2008;Accessed July 4, 2009
  20. Smith BD, Arthur DW, Buchholz TA, et al. Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). Int J Radiat Oncol Biol Phys. 2009;74:987–1001
  21. Sparano JA, Paik S. Development of the 21-gene assay and its application in clinical practice and clinical trials. J Clin Oncol. 2008;26:721–728
  22. Cardoso F, Van't Veer L, Rutgers E, et al. Clinical application of the 70-gene profile: the MINDACT trial. J Clin Oncol. 2008;26:729–735
  23. Winer EP, Hudis C, Burstein HJ, et al. American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004. J Clin Oncol. 2005;23:619–629
  24. Goldhirsch A, Ingle JN, Gelber RD, et al. Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009. Ann Oncol 2009, Advance Access published on June 17, 2009; doi:10.1093/annonc/mdp322. PMID 19535820.
  25. Drug interactions with Tamoxifen. http://www.medicine.iupui.edu/clinpharm/COBRA/TamoxifenGuide.pdfAccessed July 29, 2009

 Disclosure Information: Nothing to disclose.

 From a consensus conference focusing on nonpalpable image-detected breast cancers held in Newport Beach, CA. The conference was sponsored by the University of Southern California and supported by an educational grant from Ethicon Endo-Surgery, Inc.

PII: S1072-7515(09)01140-5

doi: 10.1016/j.jamcollsurg.2009.07.006

Journal of the American College of Surgeons
Volume 209, Issue 4 , Pages 504-520 , October 2009

Article Tools